Latest / Early Edition with Ryan Bridge / John Moffat: Bovine disease vaccine research lead on the impact of Bovine Viral Diarrhoea on costs

Transcript

John Moffat: Bovine disease vaccine research lead on the impact of Bovine Viral Diarrhoea on costs · Early Edition with Ryan Bridge

• 0:00
  Speaker 1: Research underway on a new vaccine to prevent prevalent bow
• 0:03
  Speaker 1: bine disease costs our farmers one hundred and ninety million
• 0:06
  Speaker 1: dollars every year. Three vaccines currently available are only sixty
• 0:10
  Speaker 1: to sixty five percent effective. So MPI are backing this
• 0:12
  Speaker 1: new research, which is led by John Moffatt, who is
• 0:15
  Speaker 1: with us. John, very good morning to you.
• 0:18
  Speaker 2: Good morning.
• 0:18
  Speaker 1: Is this exciting?
• 0:20
  Speaker 2: Oh? Reasonably yeah? And the violence think yes.
• 0:25
  Speaker 1: The reason I asked the question, are you on the
• 0:27
  Speaker 1: verge of something or is this sort of a fishing expedition?
• 0:32
  Speaker 2: Well, no, it's far more than a fifteen expedition, Mike.
• 0:36
  Speaker 2: The technology we're using is globally is reasonably familiar, and
• 0:43
  Speaker 2: we're adapting that technology for the New Zealand environment.
• 0:47
  Speaker 1: Really okay, so there is stuff out there that is
• 0:50
  Speaker 1: potentially more effective that if we adapted to us, then
• 0:53
  Speaker 1: we hit paid it.
• 0:57
  Speaker 2: Yes, potentially with all signs. You can't be absolutely, but yes,
• 1:00
  Speaker 2: exactly right, Miche.
• 1:01
  Speaker 1: What's the time frame on this.
• 1:06
  Speaker 2: All going? Well? We hope to be in the marketplace
• 1:10
  Speaker 2: registered in twenty twenty eight.
• 1:14
  Speaker 1: And does that have commercial implications globally? I mean, how
• 1:17
  Speaker 1: do these things work with NPI involved of you crack
• 1:19
  Speaker 1: a nut, do you get to own it, clip the ticket,
• 1:23
  Speaker 1: sell it, all of that sort of stuff, or you
• 1:24
  Speaker 1: don't work that way.
• 1:28
  Speaker 2: The partnership is a cross through organization, so MPI is
• 1:32
  Speaker 2: just one of the partners. Agra Health and jim Based
• 1:36
  Speaker 2: Animal Health Company is providing the majority of the support
• 1:41
  Speaker 2: for this project. So it ends up that they own
• 1:44
  Speaker 2: the rights to it and then we can make it
• 1:48
  Speaker 2: global essentially, but it's principally designed for the New Zealand farmers.
• 1:54
  Speaker 1: Okay, of all the things farmers face, where does bovine
• 1:59
  Speaker 1: fit and the problems around it and the lack of
• 2:01
  Speaker 1: effectiveness of the current vaccines, where.
• 2:04
  Speaker 2: Does it fit?
• 2:05
  Speaker 1: I mean, is this a major findings?
• 2:08
  Speaker 2: Are incredibly complex thing with all sorts of different threats,
• 2:12
  Speaker 2: you know, the price of fertilizer and fuel, etcetera. And
• 2:16
  Speaker 2: another animal health diseases as viral infection is probably one
• 2:20
  Speaker 2: of the most important that we deal with in the
• 2:23
  Speaker 2: cattle industry in this country. To put it in a perspective,
• 2:26
  Speaker 2: you know, it ranks up there with probably arguably with
• 2:29
  Speaker 2: things like internal parasites. As an infectious disease issue.
• 2:35
  Speaker 1: Well, we wish you the best with it. I hope
• 2:36
  Speaker 1: it goes well. We'll talk again when you crack it.
• 2:38
  Speaker 1: Nice to talk to you, John Moffatt. For more from
• 2:41
  Speaker 1: News talks'd be listen live on air or online, and
• 2:44
  Speaker 1: keep our shows with you wherever you go with our
• 2:46
  Speaker 1: podcasts on Ieart Radio